Zhiqiang An

55PUBLICATIONS
212CO-AUTHORS
Biologically active moleculesPredictive and prognostic markersMolecular targetsTumour immunologyMolecular, biological, and multi-scale communications
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (55)

|Jul 01, 2026
Antibody-oligonucleotide conjugates: an emerging modality for precision RNA therapeutics.

|Jun 03, 2026
Monoclonal antibodies targeting PCDH7 inhibit tumor growth and enhance immune responses in KRAS-mutant non-small cell lung cancer.

|Apr 14, 2026
Affinity-optimized TROP2 antibodies support potent antitumor activity in antibody-drug conjugates.

Aiko Yamaguchi, Junping Hong, Leike Li

|Apr 03, 2026
Claudins interact with LILRB immune inhibitory receptors to promote myeloid immunosuppression in cancer.

Xiaoye Liu, Ryan Huang, Zhiqiang Ku

|Mar 20, 2026
Coexpression of IL15 Promotes Effector Differentiation and Sustained Proliferative Capacity in ALPPL2-Specific Human CAR T Cells.

David Cunningham, Junquan Liu, Inci Cevher Zeytin

|Nov 27, 2025
Author Correction: Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants.

Zhiqiang Ku, Xuping Xie, Paul R Hinton

Pageof 10

Frequent Collaborators

32 joint publications

Ningyan Zhang

7 joint publications

Pei-Yong Shi

7 joint publications

Vineet D Menachery

7 joint publications

Xuping Xie